The NRG Oncology clinical trial NRG-RTOG 1010, studying the addition of the drug trastuzumab to chemoradiation ... identifying predictive biomarkers and molecular mechanisms of resistance for ...

One important limitation of trastuzumab is that it is a large molecule and does not efficiently cross the intact blood–brain barrier; thus, the central nervous system appears to serve as a ...